Phase II randomized study of dalantercept in combination with axitinib compared to axitinib alone as second-line treatment in patients with metastatic renal cell carcinoma Meeting Abstract
| Authors: | Atkins, M. B.; Bhatt, R. S.; Voss, M. H.; Rini, B. I.; Jonasch, E.; Plimack, E. R.; Alter, R.; Barger, R.; Wilson, D.; McClure, T.; Kumar, R.; Attie, K. M.; Sherman, M. L.; Pandya, S. S. |
| Abstract Title: | Phase II randomized study of dalantercept in combination with axitinib compared to axitinib alone as second-line treatment in patients with metastatic renal cell carcinoma |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419605455 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.tps4595 |
| Notes: | Meeting Abstract: TPS4595 -- Source: Wos |
